Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.

Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Fowotade, Adeola, Olagunoye, Ajibola, Ojo, Temitope Olumuyiwa, Adefuye, Bolanle Olufunlola, Fagbamigbe, Adeniyi Francis, Adebiyi, Akindele Olupelumi, Olagunju, Omobolanle Ibitayo, Ladipo, Olabode Taiwo, Akinloye, Abdulafeez
et al (show 6 more authors) (2021) Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Trials, 22 (1). 3-.

Shenkoya, Babajide, Atoyebi, Shakir ORCID: 0000-0002-1393-3753, Eniayewu, Ibrahim, Akinloye, Abdulafeez and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2021) Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester. FRONTIERS IN PEDIATRICS, 9. 734122-.

Akinloye, Abdulafeez, Eniayewu, Oluwasegun, Adeagbo, Babatunde, Bolaji, Oluseye and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2022) Validation and Clinical Application of a Liquid Chromatography-Ultraviolet Detection Method to Quantify Dolutegravir in Dried Blood Spots. THERAPEUTIC DRUG MONITORING, 44 (3). pp. 430-437.

Fowotade, Adeola, Bamidele, Folasade, Egbetola, Boluwatife, Fagbamigbe, Adeniyi F, Adeagbo, Babatunde A, Adefuye, Bolanle O, Olagunoye, Ajibola, Ojo, Temitope O, Adebiyi, Akindele O, Olagunju, Omobolanle I
et al (show 8 more authors) (2022) A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19. FRONTIERS IN MEDICINE, 9. 956123-.

This list was generated on Wed Sep 6 17:25:24 2023 BST.